Trial intelligence / Profile preview

Multitarget therapy vs standard mycophenolate mofetil for induction treatment of lupus nephritis

TCTR20200814002Phase 4Recruiting

Sponsor
N/A
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in lupus nephritis (LN), sponsored by N/A. Started Nov 2019; status: recruiting.

02

Drugs

mycophenolate mofetil
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on TCTR20200814002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200814002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call